生物活性 靶点 体外研究 体内研究 (2,2-二甲基-1-氧代丙氧基)丁酸甲酯 试剂级价格
ChemicalBook  CAS数据库列表  (2,2-二甲基-1-氧代丙氧基)丁酸甲酯

(2,2-二甲基-1-氧代丙氧基)丁酸甲酯

(2,2-二甲基-1-氧代丙氧基)丁酸甲酯,122110-53-6,结构式
(2,2-二甲基-1-氧代丙氧基)丁酸甲酯
  • CAS号:122110-53-6
  • 英文名:pivalyloxymethyl butyrate
  • 中文名:(2,2-二甲基-1-氧代丙氧基)丁酸甲酯
  • CBNumber:CB91321048
  • 分子式:C10H18O4
  • 分子量:202.25
  • MOL File:122110-53-6.mol
(2,2-二甲基-1-氧代丙氧基)丁酸甲酯化学性质
  • 沸点 :249.3±13.0 °C(Predicted)
  • 密度 :1.008±0.06 g/cm3(Predicted)
  • 储存条件 :-20°C
  • 溶解度 :DMSO: ≥10mg/mL
  • 形态 :oil
  • 颜色 :colorless or slightly yellow
安全信息
  • WGK Germany :nwg

(2,2-二甲基-1-氧代丙氧基)丁酸甲酯性质、用途与生产工艺

  • 生物活性 Pivanex (AN-9) 是丁酸的衍生物,是口服有效的 HDAC 抑制剂。Pivanex 可下调 bcr-abl 蛋白,增强凋亡 (apoptosis)。Pivanex 具有抗转移和抗血管生成的活性
  • 靶点

    HDAC

    Bcr-Abl

  • 体外研究

    Pivanex (100-500 μM) exhibits significant anti-proliferation activity in K562 cells.
    Pivanex (100-500 μM) also enhances apoptosis and caspase activity in K562 cells.
    Pivanex (200 μM) induces enhancement in the G2-M phase, a moderate enhancement in the S phase and a slight reduction in G0-G1 of the cell cycle.
    Pivanex (AN-9) has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.

    Cell Viability Assay

    Cell Line: K562 cells.
    Concentration: 100-500 μM.
    Incubation Time: 24 hours.
    Result: Reduced the number of K562 viable cells significantly.
    100 μM Pivanex with 0.125 or 0.25 μM STI571 reduced the number of viable cells synergistically.

    Apoptosis Analysis

    Cell Line: K562 cells.
    Concentration: 100-500 μM.
    Incubation Time: 6-72 hours.
    Result: Increased the number of K562 apoptotic cells significantly.
    Increased the caspase activity in K562 cells significantly after only 4 h of incubation with 500 μM.
  • 体内研究

    Pivanex (AN9, 200 mg/kg, b.i.d, daily) significantly improves the survival of SMN7 SMA mice. Pivanex (AN9) treatment also marked delays the end stage of disease as defined by the onset of body mass loss.

    Animal Model: SMN7 SMA mice (SMN2 +/+ ; SMN7 +/+ ; mSmn −/− ).
    Dosage: 200 mg/kg.
    Administration: Oral administration, b.i.d, at 09.00 and 17.00 daily.
    Result: Improved the mean lifespan of treated SMN7 SMA mice by 84.6%.
    Delayed the onset of body mass loss in SMN7 SMA mice by 94.9%.
(2,2-二甲基-1-氧代丙氧基)丁酸甲酯上下游产品信息
上游原料
下游产品
(2,2-二甲基-1-氧代丙氧基)丁酸甲酯 试剂级价格
  • 更新日期:2024/11/08
  • 产品编号:HY-120508
  • 产品名称:(2,2-二甲基-1-氧代丙氧基)丁酸甲酯 Pivanex
  • CAS编号:
  • 包装:10 mg
  • 价格:120元
  • 更新日期:2024/11/08
  • 产品编号:HY-120508
  • 产品名称:(2,2-二甲基-1-氧代丙氧基)丁酸甲酯 Pivanex
  • CAS编号:
  • 包装:25 mg
  • 价格:245元
(2,2-二甲基-1-氧代丙氧基)丁酸甲酯生产厂家
  • 公司名称:CHEMICAL LAND21
  • 联系电话:--
  • 电子邮件:sales21@chemicalland21.com
  • 国家:韩国
  • 产品数:6303
  • 优势度:74
122110-53-6, (2,2-二甲基-1-氧代丙氧基)丁酸甲酯相关搜索: